Biological effects of aspirin and clopidogrel in a randomized cross‐over study in 96 healthy volunteers
- 1 April 2006
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (4), 813-819
- https://doi.org/10.1111/j.1538-7836.2006.01867.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Overestimation of Platelet Aspirin Resistance Detection by Thrombelastograph Platelet Mapping and Validation by Conventional Aggregometry Using Arachidonic Acid StimulationJournal of the American College of Cardiology, 2005
- Cyclooxygenase-1 haplotype modulates platelet response to aspirinJournal of Thrombosis and Haemostasis, 2005
- The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosisAmerican Heart Journal, 2005
- Biological Assessment of Aspirin Efficacy on Healthy IndividualsStroke, 2005
- Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial InfarctionCirculation, 2004
- Antiplatelet Effect of Aspirin in Patients With Cerebrovascular DiseaseStroke, 2004
- Costimulation of the Gi‐coupled ADP receptor and the Gq‐coupled TXA2 receptor is required for ERK2 activation in collagen‐induced platelet aggregationFEBS Letters, 2003
- An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRNBlood, 2003
- Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphismBritish Journal of Haematology, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996